COVID-19 – A vascular disease

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to multi-system dysfunction with emerging evidence suggesting that SARS-CoV-2-mediated endothelial injury is an important effector of the virus. Potential therapies that address vascular system dysfunction and its sequelae may have a...

Descripción completa

Detalles Bibliográficos
Autores principales: Siddiqi, Hasan K., Libby, Peter, Ridker, Paul M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556303/
https://www.ncbi.nlm.nih.gov/pubmed/33068723
http://dx.doi.org/10.1016/j.tcm.2020.10.005
_version_ 1783594197457043456
author Siddiqi, Hasan K.
Libby, Peter
Ridker, Paul M
author_facet Siddiqi, Hasan K.
Libby, Peter
Ridker, Paul M
author_sort Siddiqi, Hasan K.
collection PubMed
description Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to multi-system dysfunction with emerging evidence suggesting that SARS-CoV-2-mediated endothelial injury is an important effector of the virus. Potential therapies that address vascular system dysfunction and its sequelae may have an important role in treating SARS-CoV-2 infection and its long-lasting effects.
format Online
Article
Text
id pubmed-7556303
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-75563032020-10-14 COVID-19 – A vascular disease Siddiqi, Hasan K. Libby, Peter Ridker, Paul M Trends Cardiovasc Med Article Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to multi-system dysfunction with emerging evidence suggesting that SARS-CoV-2-mediated endothelial injury is an important effector of the virus. Potential therapies that address vascular system dysfunction and its sequelae may have an important role in treating SARS-CoV-2 infection and its long-lasting effects. Elsevier Inc. 2021-01 2020-10-14 /pmc/articles/PMC7556303/ /pubmed/33068723 http://dx.doi.org/10.1016/j.tcm.2020.10.005 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Siddiqi, Hasan K.
Libby, Peter
Ridker, Paul M
COVID-19 – A vascular disease
title COVID-19 – A vascular disease
title_full COVID-19 – A vascular disease
title_fullStr COVID-19 – A vascular disease
title_full_unstemmed COVID-19 – A vascular disease
title_short COVID-19 – A vascular disease
title_sort covid-19 – a vascular disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556303/
https://www.ncbi.nlm.nih.gov/pubmed/33068723
http://dx.doi.org/10.1016/j.tcm.2020.10.005
work_keys_str_mv AT siddiqihasank covid19avasculardisease
AT libbypeter covid19avasculardisease
AT ridkerpaulm covid19avasculardisease

Ejemplares similares